# ANALYTICAL BRIEF: DRUG ENFORCEMENT ADMINISTRATION

## EXECUTIVE SUMMARY

The DEA is the lead federal agency for drug enforcement, established July 1, 1973. With ~$1.2B+ budget for opioid enforcement and 10,000 personnel worldwide, it regulates controlled substances, combats trafficking, and leads international counter-narcotics. Central to marijuana rescheduling debate.

---

## 1. OFFICIAL INFORMATION

**Full Name:** Drug Enforcement Administration
**Founding:** July 1, 1973 (Reorganization Plan No. 2)
**Current Administrator:** Terrance C. "Terry" Cole (July 23, 2025)
**Headquarters:** Arlington County, Virginia
**Parent Agency:** Department of Justice

---

## 2. BUDGET

**FY2025 Opioid Funding:** $1.2 billion
**Counter-Fentanyl Teams:** $18 million additional
**Operation Overdrive:** Expanded to 50 additional cities
**FY2024:** Only law enforcement agency with budget increase

---

## 3. ORGANIZATIONAL STRUCTURE

**Leadership:**
- Administrator (Senate-confirmed)
- Deputy Administrator
- Chief of Operations
- Chief Inspector

**Field Operations:**
- 23 Field Divisions
- 241 Domestic Offices
- 91 Foreign Offices in 68 countries

**Key Divisions:**
- Special Operations Division (SOD)
- Aviation Division (106 aircraft)
- El Paso Intelligence Center (EPIC)
- Office of Forensic Sciences

**Staff:** ~10,000 personnel (agents, analysts, chemists, support)

---

## 4. KEY PROGRAMS

### Drug Scheduling
- Five-tier federal scheduling (Schedule I-V)
- Controlled Substances Act implementation
- Temporary scheduling authority for emerging threats

### Enforcement Operations
- Lead federal agency for domestic drug enforcement
- Operation Overdrive: Intelligence-led approach
- Multi-agency task forces

### Diversion Control
- Registers manufacturers, distributors, pharmacies
- Prevents pharmaceutical diversion
- Diversion Investigators (DIs)

### Intelligence
- DEA Intelligence Division (IC member)
- Coverage: Financial, operational, strategic intelligence

---

## 5. DOCUMENTED CONTROVERSIES

### Marijuana Rescheduling (2024-2025)
- January 2025: Rescheduling hearing postponed (bias allegations)
- December 2025: Trump EO directing Schedule I to Schedule III
- DEA leadership opposes marijuana legalization
- Constitutional limitations on presidential authority
- DOT testing controversy if rescheduled

### Opioid Crisis Response
- 2014: Hydrocodone combination products rescheduled II â†’ Schedule II
- Cannabis cited as lower-risk alternative
- Chronic pain management debates

### Administrative Delays
- ALJ stayed marijuana rescheduling proceedings
- Complex rulemaking process ongoing

---

## 6. RELATIONSHIPS

- DOJ: Reports to Attorney General via Deputy AG
- FBI: Concurrent drug enforcement jurisdiction
- CBP: Concurrent jurisdiction; border cooperation
- FDA: HHS/FDA has scheduling scientific authority
- ONDCP: 2019 workgroup on synthetic opioid scheduling
- International: UN, INTERPOL liaison

---

## SOURCES

- DEA Official Website
- Congressional Research Service
- Federal Register
